Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Share Price    (VSRM)

Here is the latest stock price and chart of VENUS REMEDIES. For more details, see the VENUS REMEDIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Nov 18, 2019 09:33:00 AM
Price (Rs)24.00 Open (Rs) 24.00 High (Rs) 24.00 Low (Rs) 24.00
% Change-2.64 Volume 725 Value (Rs) 17,400 52-Week H/L 67.90 / 19.50
Live NSE Quotes Nov 18, 2019 9:31:36 AM
Price (Rs)25.00 Open (Rs) 24.65 High (Rs) 25.00 Low (Rs) 23.40
% Change1.63 Volume 319 Value (Rs) 7,733 52-Week H/L 68.00 / 18.80
Valuation
EPS (Rs)* -22.06 P/E Ratio (x) NM Market Cap (Rs m) 274.56 P/BV (x) 0.08
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors


Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

VENUS REMEDIES Share Price Today:

VENUS REMEDIES share price is down 2.6% to Rs 24.0 on the BSE. On the NSE, the VENUS REMEDIES share price is up 1.6% to Rs 25.0. The total volume of shares traded is 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.5%. And the benchmark S&P BSE SENSEX is at 40,430.3 (up 0.2%).

Over the last 30 days, the VENUS REMEDIES share price is up 10.1%. And over the last one year, VENUS REMEDIES share price is down 40.0%.





Today's Market

Bharti Airtel Q2 Numbers, Global Stock Market Drivers, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex closed higher by 70 points to end the day at 40,357.

Related Views On News

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of VENUS REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VENUS REMEDIES. Also includes updates on the valuation of VENUS REMEDIES.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints? (Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks (The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound (Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric (The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES - TEVA PHARMA COMPARISON

COMPARE VENUS REMEDIES WITH

MARKET STATS